Abstract
Mesenchymal stem cells (MSCs) are considered to be one of the most promising therapeutic cell sources as they encompass a plasticity of multiple cell lineages. The challenge in using these cells lies in developing well-defined protocols for directing cellular differentiation to generate a desired lineage. In this study, we investigated the effect of 5-azacytidine, a DNA demethylating agent, on osteogenic differentiation of MSCs. The cells were exposed to 5-azacytidine in culture medium for 24 h prior to osteogenic induction. Osteogenic differentiation was determined by several the appearance of a number of osteogenesis characteristics, including gene expression, ALP activity, and calcium mineralization. Pretreatment of MSCs with 5-azacytidine significantly facilitated osteogenic differentiation and was accompanied by hypomethylation of genomic DNA and increased osteogenic gene expression. Taking dlx5 as a representative, methylation alterations of the “CpG island shore” in the promoter caused by 5-azacytidine appeared to contribute to osteogenic differentiation.
Similar content being viewed by others
References
Anjos-Afonso F, Siapati EK et al (2004) In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117:5655–5664. doi:10.1242/jcs.01488
Antonitsis P, Ioannidou-Papagiannaki E et al (2007) In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells: the role of 5-azacytidine. Interact Cardiovasc Thorac Surg 6:593–597. doi:10.1510/icvts.2007.157875
Avbersek-Luznik I, Gmeiner Stopar T et al (2007) Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation. Clin Chem Lab Med 45:1014–1018. doi:10.1515/CCLM.2007.186
Burlacu A, Rosca AM et al (2008) Promoting effect of 5-azacytidine on the myogenic differentiation of bone marrow stromal cells. Eur J Cell Biol 87:173–184. doi:10.1016/j.ejcb.2007.09.003
Chen J, Ghazawi FM et al (2006) Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B. Mol Cancer 5:71. doi:10.1186/1476-4598-5-71
Chen TH, Chen WM et al (2007) Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 355:913–918. doi:10.1016/j.bbrc.2007.02.057
Chen Y, Shao JZ et al (2008) Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol 40:815–820. doi:10.1016/j.biocel.2008.01.007
Christman JK (2002) 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21:5483–5495. doi:10.1038/sj.onc.1205699
Delorme B, Chateauvieux S et al (2006) The concept of mesenchymal stem cells. Regen Med 1:497–509. doi:10.2217/17460751.1.4.497
Dimai HP, Linkhart TA et al (1998) Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice. Bone 22:211–216. doi:10.1016/S8756-3282(97)00268-8
Dominici M, Le Blanc K et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317. doi:10.1080/14653240600855905
Egger G, Aparicio AM et al (2007) Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2′-deoxycytidine treatment. Cancer Res 67:346–353. doi:10.1158/0008-5472.CAN-06-2845
Fang JY, Lu YY (2002) Effects of histone acetylation and DNA methylation on p21 (WAF1) regulation. World J Gastroenterol 8:400–405
Fouse SD, Shen Y et al (2008) Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2:160–169. doi:10.1016/j.stem.2007.12.011
Freimoser FM, Jakob CA et al (1999) The MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities. Appl Environ Microbiol 65:3727–3729
Halaban R, Krauthammer M et al (2009) Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS ONE 4:e4563. doi:10.1371/journal.pone.0004563
Harder J, Engelstaedter V et al (2009) CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients. Br J Cancer 100:360–365. doi:10.1038/sj.bjc.6604859
Hosseinkhani M, Hasegawa K et al (2007) Trichostatin A induces myocardial differentiation of monkey ES cells. Biochem Biophys Res Commun 356:386–391. doi:10.1016/j.bbrc.2007.02.151
Hsieh J, Nakashima K et al (2004) Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 101:16659–16664. doi:10.1073/pnas.0407643101
Imre R, Fekete P (1983) A rapid technique for alkaline phosphatase enzyme activity in tissues. Acta Histochem 73:17–21
Irizarry RA, Ladd-Acosta C et al (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41:178–186. doi:10.1038/ng.298
Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev 4:988–993
Jaiswal RK, Jaiswal N et al (2000) Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645–9652. doi:10.1074/jbc.275.13.9645
Juttermann R, Li E et al (1994) Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA 91:11797–11801. doi:10.1073/pnas.91.25.11797
Koc ON, Lazarus HM (2001) Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 27:235–239. doi:10.1038/sj.bmt.1702791
Liu Y, Song J et al (2003) Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc Res 58:460–468. doi:10.1016/S0008-6363(03)00265-7
Locklin RM, Oreffo RO et al (1998) Modulation of osteogenic differentiation in human skeletal cells in vitro by 5-azacytidine. Cell Biol Int 22:207–215. doi:10.1006/cbir.1998.0240
Meijer GJ, de Bruijn JD et al (2007) Cell-based bone tissue engineering. PLoS Med 4:e9. doi:10.1371/journal.pmed.0040009
Sato F, Meltzer SJ (2006) CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 106:483–493. doi:10.1002/cncr.21657
Sulewska A, Niklinska W et al (2007) DNA methylation in states of cell physiology and pathology. Folia histochemica et cytobiologica / Polish Academy of Sciences. Pol Histochem Cytochem Soc 45:149–158
Teodoridis JM, Hardie C et al (2008) CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 268:177–186. doi:10.1016/j.canlet.2008.03.022
Wu YH, Tsai Chang JH et al (2007) Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Oncogene 26:4761–4773. doi:10.1038/sj.onc.1210284
Yeo S, Jeong S et al (2007) Characterization of DNA methylation change in stem cell marker genes during differentiation of human embryonic stem cells. Biochem Biophys Res Commun 359:536–542. doi:10.1016/j.bbrc.2007.05.120
Acknowledgments
This work was supported by grant J20020579-30116 from the Key Science and Technology Foundation of Zhejiang Province, People’s Republic of China.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Guo-Shun Zhou and Xiao-Lei Zhang contributed equally.
Rights and permissions
About this article
Cite this article
Zhou, GS., Zhang, XL., Wu, JP. et al. 5-Azacytidine facilitates osteogenic gene expression and differentiation of mesenchymal stem cells by alteration in DNA methylation. Cytotechnology 60, 11–22 (2009). https://doi.org/10.1007/s10616-009-9203-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-009-9203-2